Tibet Rhodiola Pharmaceutical (600211.SHG) Q3 2024 Earnings

13AugConfirmed
Mar 22
Apr 22
Q2 2024
Q3 2024
-0.85
-0.33
0.19
0.7

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Tibet Rhodiola Pharmaceutical (600211.SHG) will report earnings of for Q3 2024 on August 13, 2024.

0 Comments

Share your thoughts